Practice Guideline
doi: 10.1053/j.gastro.2013.10.047.
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease
Collaborators,
Affiliations
- PMID: 24267474
- DOI: 10.1053/j.gastro.2013.10.047
Item in Clipboard
Practice Guideline
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease
Gastroenterology.
2013 Dec.
No abstract available
Keywords: AGA; American Gastroenterological Association Institute; CD; Crohn's disease; Development and Evaluation; GRADE; Grading of Recommendations Assessment; PICO; TNF; and outcome; comparator; intervention; population; tumor necrosis factor.
Similar articles
-
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.Gastroenterology. 2013 Dec;145(6):1464-78.e1-5. doi: 10.1053/j.gastro.2013.10.046. Gastroenterology. 2013. PMID: 24267475 Review. No abstract available.
-
Therapeutic role of methotrexate in pediatric Crohn's disease.Bosn J Basic Med Sci. 2018 Aug 1;18(3):211-216. doi: 10.17305/bjbms.2018.2792. Bosn J Basic Med Sci. 2018. PMID: 29338679 Free PMC article. Review.
-
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.World J Gastroenterol. 2016 Dec 14;22(46):10103-10117. doi: 10.3748/wjg.v22.i46.10103. World J Gastroenterol. 2016. PMID: 28028358 Free PMC article. Review.
-
Methotrexate for Crohn's disease.N Engl J Med. 1995 Aug 31;333(9):600-1. doi: 10.1056/NEJM199508313330917. N Engl J Med. 1995. PMID: 7623920 No abstract available.
-
T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2. Am J Gastroenterol. 2013. PMID: 23032984
Cited by
-
Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus.BMJ Open Gastroenterol. 2024 Jan 23;11(1):e001246. doi: 10.1136/bmjgast-2023-001246. BMJ Open Gastroenterol. 2024. PMID: 38267072 Free PMC article. Review.
-
Knowledge, attitude, and practice of patients living with inflammatory bowel disease: A cross-sectional study.World J Gastroenterol. 2023 Nov 21;29(43):5818-5833. doi: 10.3748/wjg.v29.i43.5818. World J Gastroenterol. 2023. PMID: 38074915 Free PMC article.
-
Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II.BMC Complement Med Ther. 2023 Jul 11;23(1):230. doi: 10.1186/s12906-023-04062-0. BMC Complement Med Ther. 2023. PMID: 37434218 Free PMC article.
-
Chitosan functionalized Mn3O4 nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox state.Commun Biol. 2023 Jun 16;6(1):647. doi: 10.1038/s42003-023-05023-6. Commun Biol. 2023. PMID: 37328528 Free PMC article.
-
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD.Crohns Colitis 360. 2021 May 13;3(3):otab023. doi: 10.1093/crocol/otab023. eCollection 2021 Jul. Crohns Colitis 360. 2021. PMID: 36776639 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
